Q: We have received rejections for claims reporting the application of skin substitutes, with the edit stating there is a mismatch of the procedure and the skin substitute. We are using the table that was published in the 2017 OPPS final rule. Has something changed?
Q: We are having an internal disagreement regarding HCPCS code G0498. Our clinical department believes that this code is to be reported in addition to the chemotherapy administration charge. Our coders and chargemaster coordinator disagree and believe it is an all-inclusive code. Who’s right?
